2013 PCNA Fall Program - Series I

Educational objectives:
Upon completion of this program, participants will be able to:

Secondary Prevention of CVD: Best Practices Based on the Evidence (50% pharm)

  • Distinguish the pharmacologic profiles of current U. S. approved oral antiplatelet therapies. Identify strategies to promote adherence of secondary prevention recommendations for CVD. 
  • Summarize current evidence-based pharmacologic recommendations in secondary prevention of CVD 


Safe and Effective Dyslipidemia Management in Patients with Diabetes (DM) and Chronic Kidney Disease (CKD) (75% pharm)

 

  • Describe common lipid abnormalities in patients with DM or CKD. 
  • Identify recommendations for dosing adjustments in statin therapy for these patients. 
  • Apply evidence based recommendations for dyslipidemia therapy in these patients. 


Lost in Transition: Keeping Heart Failure Patients from Falling Through the Cracks (0 % pharm)

 

 

  • Identify the clinical presentation and appropriate diagnostic tests for systolic (HFrEF) and diastolic heart failure (HFpEF). 
  • Identify the barriers that deter effective self care management in heart failure patients. 
  • Apply transition of care strategies in a heart failure case study.

 

Content Reviewed Date: January 2017

 

 

 

Seminar Information
Seminar Date:
October 19, 2013
Secondary Prevention of CVD: Best Practices Based on the Evidence (50% pharm)

Educational objectives:
Upon completion of this program, participants will be able to:

Distinguish the pharmacologic profiles of current U. S. approved oral antiplatelet therapies. Identify strategies to promote adherence of secondary prevention recommendations for CVD.
Summarize current evidence-based pharmacologic recommendations in secondary prevention of CVD

Speaker Information
Kristen Hillebrand PharmD, BCPS   [ view bio ]
Safe and Effective Dyslipidemia Management in Patients with Diabetes (DM) and Chronic Kidney Disease (CKD) (75% pharm)

Educational objectives:
Upon completion of this program, participants will be able to:

Describe common lipid abnormalities in patients with DM or CKD.
Identify recommendations for dosing adjustments in statin therapy for these patients.
Apply evidence based recommendations for dyslipidemia therapy in these patients.

Speaker Information
Dr. Eli M Roth MD, FACC   [ view bio ]
Lost in Transition: Keeping Heart Failure Patients from Falling Through the Cracks (0 % pharm)

Educational objectives:
Upon completion of this program, participants will be able to:

Identify the clinical presentation and appropriate diagnostic tests for systolic (HFrEF) and diastolic heart failure (HFpEF).
Identify the barriers that deter effective self care management in heart failure patients.
Apply transition of care strategies in a heart failure case study.

Speaker Information
Linda Baas RN, PhD, ACNP, CHFN   [ view bio ]
Individual topic purchase: Selected

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.


ACCREDITOR:

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. 

 

Preventive Cardiovascular Nurses Association
Contact Hour Total: 2.25
Products
2013 Lecture Program I
This seminar is presented free of charge.